Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin for Antimicrobial Prophylaxis in Cardiac Surgery
NCT00572260Phase 4Terminated
- Sponsor
- Duke University
- Start
- Jan 2008
- Primary completion
- Sep 2008
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of daptomycin in surgical site infection (SSI) and Staphylococcus aureus infection, sponsored by Duke University. Primary endpoint: Rate of Patients Receiving Antimicrobial Prophylaxis Within the Appropriate Timeframe Before Incision at 30 days. Started Jan 2008; status: terminated.
02
Drugs
daptomycin
03
Conditions
surgical site infection (SSI)Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT00572260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00572260.